B7S Stock Overview
Owns, manages, and operates senior living communities in the United States.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Brookdale Senior Living Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$5.75 |
52 Week High | US$7.35 |
52 Week Low | US$3.80 |
Beta | 1.32 |
11 Month Change | -2.54% |
3 Month Change | -17.86% |
1 Year Change | 48.20% |
33 Year Change | 0.88% |
5 Year Change | -12.88% |
Change since IPO | -71.25% |
Recent News & Updates
Recent updates
Shareholder Returns
B7S | DE Healthcare | DE Market | |
---|---|---|---|
7D | 0.9% | -1.9% | -1.8% |
1Y | 48.2% | 24.7% | 13.2% |
Return vs Industry: B7S exceeded the German Healthcare industry which returned 26.3% over the past year.
Return vs Market: B7S exceeded the German Market which returned 16.1% over the past year.
Price Volatility
B7S volatility | |
---|---|
B7S Average Weekly Movement | 5.6% |
Healthcare Industry Average Movement | 3.7% |
Market Average Movement | 5.0% |
10% most volatile stocks in DE Market | 11.5% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: B7S has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: B7S's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | 30,600 | Cindy Baier | www.brookdale.com |
Brookdale Senior Living Inc. owns, manages, and operates senior living communities in the United States. It operates in three segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRCs). The Independent Living segment owns or leases communities comprising independent and assisted living units in a single community that are primarily designed for middle to upper income seniors.
Brookdale Senior Living Inc. Fundamentals Summary
B7S fundamental statistics | |
---|---|
Market cap | €1.15b |
Earnings (TTM) | -€191.25m |
Revenue (TTM) | €2.70b |
0.4x
P/S Ratio-6.0x
P/E RatioIs B7S overvalued?
See Fair Value and valuation analysisEarnings & Revenue
B7S income statement (TTM) | |
---|---|
Revenue | US$2.92b |
Cost of Revenue | US$2.14b |
Gross Profit | US$781.40m |
Other Expenses | US$988.64m |
Earnings | -US$207.24m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 06, 2024
Earnings per share (EPS) | -1.04 |
Gross Margin | 26.75% |
Net Profit Margin | -7.09% |
Debt/Equity Ratio | 1,094.6% |
How did B7S perform over the long term?
See historical performance and comparison